A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
Purpose: The C-TRIUMPH study has identified 20 household contacts (HHC), who have progressed to active TB from its HHCs cohort...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...